Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling.
about
High-dimensional omics data analysis using a variable screening protocol with prior knowledge integration (SKI)Novel drugs targeting the epidermal growth factor receptor and its downstream pathways in the treatment of colorectal cancer: a systematic reviewMechanisms of acquired resistance to ERK1/2 pathway inhibitors.Targeting the Ras-ERK pathway in pancreatic adenocarcinoma.Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy.Dual inhibition of MEK1/2 and EGFR synergistically induces caspase-3-dependent apoptosis in EGFR inhibitor-resistant lung cancer cells via BIM upregulation.Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas.
P2860
Q36268787-B7CDC2A4-6E0F-4126-B4E6-8D2E599479B8Q36337063-0DC636A7-689A-4CF3-B3CB-7C132D9D7F43Q38007869-5C9BEB4D-54CA-4038-8523-B42B1B9486C3Q38053855-C446BA43-6EEF-4D61-99A8-633A50E30212Q38585847-50AB30B5-B939-4603-B885-FCAB0B568C0AQ39091696-AC7FD88B-54CE-4FCA-B3CB-3621912B7612Q48278060-BFD139A1-B4C9-4554-A1B0-AE57E91BCDE0
P2860
Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling.
@en
Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling.
@nl
type
label
Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling.
@en
Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling.
@nl
prefLabel
Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling.
@en
Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling.
@nl
P2093
P2860
P356
P1476
Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling.
@en
P2093
Annette S Little
Kathryn Balmanno
Matthew J Sale
Paul D Smith
Simon J Cook
P2860
P356
10.1042/BST20110647
P577
2012-02-01T00:00:00Z